tiprankstipranks
Rite Aid (RADCQ)
OTHER OTC:RADCQ

Rite Aid (RADCQ) Technical Analysis

1,999 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Rite Aid’s (RADCQ) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Rite Aid is a Sell.
Rite Aid’s (RADCQ) 20-Day exponential moving average is 0.11, while Rite Aid’s (RADCQ) share price is $0.16, making it a Buy.
Rite Aid’s (RADCQ) 50-Day exponential moving average is 0.16, while Rite Aid’s (RADCQ) share price is $0.16, making it a Buy.

Rite Aid (RADCQ) Pivot Points

Apr 18, 2024, 08:34 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.07
0.08
0.09
0.10
0.11
0.12
0.13
Fibonacci
0.08
0.09
0.09
0.10
0.11
0.11
0.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Rite Aid (RADCQ) Moving Averages

Apr 18, 2024, 08:34 PM
Period
Simple
Exponential
MA5
0.12Buy
0.12Buy
MA10
0.11Buy
0.11Buy
MA20
0.09Buy
0.11Buy
MA50
0.18Sell
0.16Buy
MA100
0.21Sell
0.30Sell
MA200
0.72Sell
0.79Sell
Rite Aid’s (RADCQ) 10-Day exponential moving average is 0.11, while Rite Aid’s (RADCQ) share price is $0.16, making it a Buy.
Rite Aid’s (RADCQ) 100-Day exponential moving average is 0.30, while Rite Aid’s (RADCQ) share price is $0.16, making it a Sell.
Rite Aid’s (RADCQ) stock price is $0.16 and Rite Aid’s (RADCQ) 50-day simple moving average is 0.18, creating a Sell signal.
Rite Aid’s (RADCQ) stock price is $0.16 and Rite Aid’s (RADCQ) 100-day simple moving average is 0.21, creating a Sell signal.
Rite Aid’s (RADCQ) stock price is $0.16 and Rite Aid’s (RADCQ) 200-day simple moving average is 0.72, creating a Sell signal.

Rite Aid (RADCQ) Technical Indicators

Apr 18, 2024, 08:34 PM
Name
Value
Implied Action
RSI (14)
55.26
Neutral
STOCH (9,6)
38.94
Neutral
STOCHRSI (14)
27.02
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
45.88
Neutral
Williams %R
-64.00
Buy
CCI (14)
106.60
Sell
ATR (14)
0.10
-
Ultimate Oscillator
39.30
Neutral
ROC
77.78
Buy
Rite Aid’s (RADCQ) Relative Strength Index (RSI) is 55.26, creating a Neutral signal.
Rite Aid’s (RADCQ) Trend Strength Indicator (ADX) is 45.88, creating a Neutral signal.
Rite Aid’s (RADCQ) Commodity Channel Index (CCI) is 106.60, creating a Sell signal.
Rite Aid’s (RADCQ) Price Rate of Change (ROC) is 77.78, creating a Buy signal.

FAQ

Is RADCQ a Buy, Hold, or Sell?
Based on RADCQ’s technical indicators, RADCQ is a Buy.
    What is RADCQ’s RSI (14)?
    RADCQ’s RSI (14) is 55.26, which suggests RADCQ is a Neutral.
      What is RADCQ’s MACD?
      RADCQ’s MACD is -0.01, which suggests RADCQ is a Sell.
        What is RADCQ’s 5-day moving average?
        RADCQ’s 5-day moving average is 0.12, which suggests RADCQ is a Buy.
          What is RADCQ’s 20-day moving average?
          RADCQ 20-day moving average is 0.09, which suggests RADCQ is a Buy.
            What is RADCQ’s 50-day moving average?
            RADCQ’s 50-day moving average is 0.18, which suggests RADCQ is a Sell.
              What is RADCQ’s 200-day moving average?
              RADCQ’s 200-day moving average is 0.72, which suggests RADCQ is a Sell.
                What is RADCQ’s Williams % R (14)?
                RADCQ’s Williams % R (14) is -64.00, which suggests RADCQ is a Buy.
                  What is RADCQ’s CCI (14)?
                  RADCQ’s CCI (14) is 106.60, which suggests RADCQ is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis